Literature DB >> 15292663

Fluphenazine and its toxic maculopathy.

M S Lee1, A I Fern.   

Abstract

Ten years ago a 45-year-old female presented with bilateral maculopathy with visual acuity of 6/18 on the right and 6/24 on the left. She had been on fluphenazine for the past 10 years for schizophrenia. Investigation including fluorescein angiogram, colour vision assessment and electrophysiological testing confirmed the nature of the retinal damages. Her maculopathy deteriorated further despite discontinuation of the medication. A previous publication has reported maculopathy with fluphenazine in association with the welding arc injury, but that particular patient had not been exposed to welding flash or other extreme photochemical sources. We believe this is the first reported incidence that fluphenazine has directly caused a maculopathy secondary to its accumulation at the retinal pigment epithelium and its toxic effect.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292663     DOI: 10.1159/000078784

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  3 in total

1.  Schizophrenia and the retina: Towards a 2020 perspective.

Authors:  Steven M Silverstein; Samantha I Fradkin; Docia L Demmin
Journal:  Schizophr Res       Date:  2019-11-07       Impact factor: 4.939

2.  Aripiprazole-induced chorioretinopathy: multimodal imaging and electrophysiological features.

Authors:  Céline Faure; Isabelle Audo; Christina Zeitz; Jean-Bernard Letessier; Matthieu P Robert
Journal:  Doc Ophthalmol       Date:  2015-03-20       Impact factor: 2.379

3.  Schizophrenia and the eye.

Authors:  Steven M Silverstein; Richard Rosen
Journal:  Schizophr Res Cogn       Date:  2015-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.